Longeveron® Appoints Than Powell as Chief Business Officer

About this update from Longeveron Inc.

[{"type":"image","alt":"Longeveron","displaySize":"","headline":null,"caption":"Longeveron","className":"","disableSlideshowImg":false,"size":{"original":{"width":300,"height":56,"url":"https://media.zenfs.com/en/globenewswire.com/7020f3e4e4ad01a05af1150b74d0406a"},"resized":{"url":"https://s.yimg.com/ny/api/res/1.2/.X2J.blw.0f9XkdGnRbwAQ--/YXBwaWQ9aGlnaGxhbmRlcjt3PTQyMDtoPTc4O2NmPXdlYnA-/https://media.zenfs.com/en/globenewswire.com/7020f3e4e4ad01a05af1150b74d0406a","width":300,"height":56}},"lazy":false},{"type":"list","items":[{"val":[{"type":"text","content":"Mr. Powell to oversee Longeveron’s partnering and international strategy efforts","length":80,"tagName":"p"}]}],"tagName":"ul","bulletedList":true,"length":80,"olType":false},{"type":"text","content":"MIAMI, June 26, 2025 (GLOBE NEWSWIRE) -- Longeveron Inc. (NASDAQ: LGVN), a clinical stage regenerative medicine biotechnology company developing cellular therapies for life-threatening and chronic aging-related conditions, today announced that it has appointed Than Powell as Chief Business Officer, effective July 7, 2025. In this role, he will lead the Company’s overall business strategy, Alzheimer’s disease program partnering efforts, and international strategy for the hypoplastic left heart syndrome (HLHS) program.","length":522,"tagName":"p"},{"type":"text","content":"“We are delighted to have Than join Longeveron at this transformational time in the Company’s development,” said Wa’el Hashad, Chief Executive Officer at Longeveron. “With the recent completion of enrollment of our pivotal Phase 2 trial evaluating our stem cell therapy laromestorcel for HLHS, we are approximately 13 months from top-line data, which, if positive, would be the foundation for the company’s first Biological License Application (BLA) submission. Than’s experience across multiple pharmaceutical and biotechnology companies will help guide Longeveron’s efforts to build on the clinical success of laromestorcel to date through partnering strategy for Alzheimer’s disease and international strategy for HLHS.”","length":723,"tagName":"p"},{"type":"text","content":""I am thrilled to join Longeveron,” said Than Powell, Chief Business Officer at Longeveron. “The scientific rigor and ground-breaking innovation at the heart of Longeveron’s stem cell research is inspiring, especially as my family has been impacted by some of the d...

More updates from Longeveron Inc.